The effect of the neuropeptide substance P (SP) on human mast cell (MC) phenotype is poorly understood. In this study, SP effects on human MC expression of the high affinity IgE receptor (FcεRI) were characterized. SP downregulated expression of FcεRI mRNA and protein by approximately 50% and in a concentration dependent manner, the effect was partially mediated by engagement of the neurokinin-1 receptor (NK1R) and resulted in reduced mast cell activation. Sensitization of MC with IgE prior to SP exposure protected MC from SP-mediated FcεRI downregulation. SP release may inhibit MC responses to allergens and these results may have implications in neuroinflammatiion and stress.
Introduction
Mast cells are storehouses of potent immunomodulatory mediators and play a central role in allergic inflammation and innate immune responses. In allergic disease, mast cells are activated when IgE bound to the Fcε receptor I (FcεRI) on the cell surface is crosslinked by specific antigen, triggering mast cell release of granule-contained mediators by degranulation and de novo synthesis of arachidonic acid metabolites, cytokines and chemokines. Mast cell production of these numerous vasoactive, nociceptive and proinflammatory molecules facilitates their interaction with nearby cells and initiates the allergic response (Galli et al., 2005) .
In addition to their role in allergic inflammation, mast cells are important in the modulation of neuroimmune responses, particularly in wound repair during colitis (Bulut et al., 2008) and in burns (Kawahira et al., 2008) . In the absence of sensory neurons, mast cell-driven skin inflammation is impaired, implying that cutaneous nerves augment mast cell (MC)-driven inflammatory responses by releasing neuropeptides (Siebenhaar et al., 2008) . Neuropeptides activate mast cells in an FcεRI-independent manner (Bienenstock et al., 1991) and initiate unique signaling pathways that result in the release of a distinct array of mediators from that triggered by FcεRI-mediated activation. Thus, it appears that mast cells can regulate nerve function and nerve cellderived neuropeptides can counter-regulate mast cell function. We have previously shown that substance P (SP) activates human mast cell degranulation and chemokine production by a Pertussis-sensitive mechanism (Kulka et al., 2008) . In this study, the long-term effect of SP on mast cell expression of FcεRI was characterized.
Materials and methods

Human mast cell culture
LAD2 MC (Kirshenbaum et al., 2003) were cultured in serum free medium (StemPro-34 SFM, Life Technologies, Rockville, MD) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 50 µg/ml streptomycin and 100 ng/ml stem cell factor (SCF). The cell suspensions were seeded at a density of 105 cells/ml and maintained at 37°C and 5% CO 2 . Cells were fed by hemi-depletion and replacement of medium once per week.
Human peripheral blood derived CD34 + cells were cultured in StemPro-34 SFM supplemented with 2 mM L-glutamine, 50 μg/ml streptomycin, 100 IU/ml penicillin, 100 ng/ml SCF, and 100 ng/ml recombinant human IL-6 (PeproTech, Inc., Rocky Hill, NJ). Recombinant human IL-3 (30 ng/ml) was added for the first week. Half of the culture medium was replaced every 7 days. Cultures at 8 to 10 weeks consisted of greater than 99% human mast cells (huMC) (Kirshenbaum et al., 1999) . Unless otherwise stated, experiments were performed in StemPro-34 SFM complete with 10 ng/ml SCF.
